Hirschsprung's-associated Enterocolitis

Management of Hirschsprung's-associated enterocolitis begins with clinical recognition: in patients with prior Hirschsprung diagnosis presenting with distention, irritability, and fever, enterocolitis should be assumed until proven otherwise. Initial treatment comprises three key components: rectal irrigations, intravenous fluids, and antibiotics. This empiric approach is safe even if the final diagnosis differs. A rectal examination should be performed cautiously, stepping to the side due to risk of explosive stool and gas release. Management requires collaboration between surgery and gastroenterology. Long-term prevention addresses the underlying poorly functioning sphincter through conservative measures and, in refractory cases, interventions such as Botox or colonic manometry to guide therapy.

Experts disagree on whether colectomy should be performed at the time of total colon Hirschsprung diagnosis because of enterocolitis risk. Beyond this surgical question, the field acknowledges fundamental uncertainty: the actual pathophysiology of Hirschsprung-associated enterocolitis has not been pinpointed. Management itself is described as controversial, though consensus exists on empiric treatment (rectal irrigations, IV fluids, antibiotics) for suspected cases, which causes no harm even if the diagnosis differs.